Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

BUY
$28.0 - $40.56 $73,192 - $106,023
2,614 Added 12.24%
23,967 $972,000
Q3 2022

Nov 14, 2022

BUY
$29.63 - $48.31 $47,082 - $76,764
1,589 Added 8.04%
21,353 $706,000
Q2 2022

Aug 12, 2022

BUY
$27.79 - $50.61 $549,241 - $1 Million
19,764 New
19,764 $696,000
Q4 2019

Feb 10, 2020

SELL
$28.14 - $73.01 $285,930 - $741,854
-10,161 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$26.26 - $34.86 $266,827 - $354,212
10,161 New
10,161 $286,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.11B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.